Tag: nasdaq:zyne

January 16, 2020

New Cannabis ETF Makes European Debut

Purpose Investments participated in the debut of the Medical Cannabis & Wellness UCITS ETF, which offers cannabis exposure to Europeans.
August 13, 2019

Are US Marijuana Stocks a Good Buy?

The US has emerged as a cannabis powerhouse, but are US marijuana stocks a good buy for the average investor?
May 19, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Index in Green

Last week's top NASDAQ biotech and pharma stocks were Harrow Health, Sesen Bio, Zynerba Pharmaceuticals, Athersys and Catalyst Pharmaceuticals.
May 6, 2019

Zynerba Jumps on Fast Track Designation Approval

The company has received fast track designation for its lead candidate, Zygel, which aims to treat patients with Fragile X...
May 6, 2019

Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™

Zynerba Pharmaceuticals (NASDAQ:ZYNE) has announced that the US Food and Drug Administration (FDA) has given fast track designation for the...
April 28, 2019

5 Top Weekly NASDAQ Biotech Stocks: Aratana Soars on Acquisition

Last week's other top NASDAQ biotech stocks were X4 Pharmaceuticals, Zynerba Pharmaceuticals, Vaccinex and Marinus Pharmaceuticals.
March 18, 2019

Investing in Cannabis Biotech Stocks

Investors have gained new options in the marijuana space thanks to the emergence of cannabis biotech stocks working on new...